Skip to main content
Fig. 1 | Trials

Fig. 1

From: Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial

Fig. 1

Time and events scheduled for patients enrolled into the DASH-RCT. *Refers to the first day post-allocation. 1Routine antimicrobial susceptibility testing is performed on the first methicillin-susceptible Staphylococcus aureus isolate of each patient. 2The minimal inhibitory concentration (MIC) to daptomycin is performed by Etest® on the first methicillin-susceptible S. aureus isolate of each patient. 3Two sets of blood cultures are obtained daily for 5 days or until microbiological clearance is documented, whichever is longer. 4Hepatic profile includes aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, and total bilirubin. 5Electrolytes include sodium, potassium, chloride, and bicarbonate. 6A symptom questionnaire is administered on day 5 to assess patients for nausea, vomiting, headaches, and myalgia

Back to article page

Trials

ISSN: 1745-6215